Abstract
Mammals have innate and adaptive defenses that protect them from virus infections. Viruses, in particular the large DNA viruses (adenoviruses, herpesviruses, poxviruses), have evolved mechanisms that counteract the host’s antiviral defenses. In general, these viruses prevent killing of infected cells by cytotoxic T lymphocytes (CTL), block the inflammatory response, inhibit complement fixation, prevent shut-off of cellular protein synthesis in response to interferon, and block apoptosis (which may be a host defense against virus infection). Reviews have appeared recently on how some of these proteins function (Gooding 1992; G.L. Smith 1994). Here we will focus on the human adenoviruses, in particular the E3 transcription unit, which appears to be, at least in part, a cassette of genes that functions to counteract the host’s antiviral defenses. Recent reviews on this topic are by Pääbo et al. (1989), Wold and Gooding (1989, 1991), Gooding and Wold (1990), Gooding (1992), and Wold (1993).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abraham SE, Lobo S, Yaciuk P, Wang H-GHW, Moran E (1993) p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8: 1639–1647
Ames RS, Holskin B, Mitcho M, Shalloway D, Chen M-J (1990) Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J Virol 64: 4115–4122
Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance, Cell 43: 215–222
Andersson M, McMichael A, Peterson PA (1987) Reduced allorecognition of adenovirus-2 infected cells. J Immunol 138: 3960–3966
Baker CC, Ziff EB (1981) Promoters and heterogeneous 5’ termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol 149: 189–221
Beg AA, Finco TS, Nantermet PV, Baldwin AS (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of Iκβα: a mechanism for NF-κβ activation. Mol Cell Biol 13: 3301–3310
Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH (1994) Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 152: 3862–3872
Berk AJ, Sharp PA (1978) Structure of the adenovirus 2 early mRNAs. Cell 14: 695–711
Berk AJ, Lee F, Harrison T, Williams J, Sharp P (1979) Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell 17: 935–944
Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zijlstra M, Melief CJM (1983) Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305: 776–779
Beutler B, van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667–668
Bhat BM, Wold WSM (1985) ATTAAA as well as downstream sequences are required for RNA 3’-end formation in the E3 complex transcription unit of adenovirus. Mol Cell Biol 5: 3183–3193
Bhat BM, Wold WSM (1986a) Genetic analysis of mRNA synthesis in region E3 of adenovirus at different stages of infection by RNA processing mutants. J Virol 60: 54–63
Bhat BM, Wold WSM (1986b) Adenovirus mutants with splice-enhancing mutations in the E3 complex transcription unit are also defective in E3A RNA 3’-end formation. J Virol 57: 1155–1158
Bhat BM, Wold WSM (1987) A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus. J Virol 61: 3938–3945
Bhat BM, Brady HA, Pursley MH, Wold WSM (1986) Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus. J Mol Biol 190: 543–557
Binger MH, Flint SJ (1984) Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology 136: 387–403
Brady HA, Wold WSM (1987) Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Res. 15: 9397–9416
Brady HA, Wold WSM (1988) Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized. Mol Cell Biol 8: 3291–3297
Brady HA, Scaria A, Wold WSM (1992) Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J Virol 66: 5914–5923
Brandt CD, Kim HW, Vargosko AJ, Jeffries BC, Arrobio JO, Rindge B, Parrott RH, Chanock RM (1969) Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol 90: 484–500
Buckbinder L, Miralles VJ, Reinberg D (1989) TPA can overcome the requirement for E1a and together act synergistically in stimulating expression of the adenovirus E3 promoter. EMBO J 8: 4239–4250
Burgert H-G, Kvist S (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987–997
Burgert H-G, Kvist S (1987) The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J 6: 2019–2026
Burgert H-G, Maryanski JL, Kvist S (1987) “E3/19K” protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 84: 1356–1360
Carlin CR, Tollefson AE, Brady HA, Hoffman BL, Wold WSM (1989) Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded bythe E3 region of adenovirus. Cell 57:135–144
Chang DJ, Ringold GM, Heller RA (1992) Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun 188: 538–546
Chen M-J, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M, Shalloway D (1987) Induction by E/A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330: 581–583
Chow LT, Broker TR (1978) The spliced structures of adenovirus 2 fiber message and the other late mRNAs. Cell 15: 497–510
Chow LT, Roberts JM, Lewis JB, Broker TR (1977) A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids. Cell 11: 819–836
Chow LT, Lewis JB, Borker TR (1979a) RNA transcription and splicing at early and intermediate times after adenovirus-2 infection. Cold Spring Harbor Symp Quant Biol 44: 401–414
Chow LT, Broker TR, Lewis JB (1979b) Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol 134: 265–303
Cladaras C, Wold WSM (1985) DNA sequence of the early E3 transcription unit of adenovirus 5. Virology 140: 28–43
Cladaras C, Bhat BM, Wold WSM (1985) Mapping the 5’ends, 3’ ends, and splice sites of mRNAs from the E3 transcription unit of adenovirus 5. Virology 140: 44–54
Clark JD, Lin L-L, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043–1051
Cousin C, Winter N, Gomes SA, D’Halluin JC (1991) Cellular transformation of E1 genes of enteric adenoviruses. Virology 181: 277–287
Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715–718
Cox JH, Bennink JR, Yewdell JW (1991) Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 174: 1629–1637
Dahllöf B, Wallin M, Kvist S (1991) The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus-2 is microtubule binding. J Biol Chem 266: 1804–1808
Davison AJ, Telford AR, Watson MS, McBride K, Mautner V (1993) The DNA sequence of adenovirus type 40. J Mol Biol 234: 1308–1316
Dbaibo GS, Obeid LM, Hannun YA (1993) Tumor necrosis factor-a (TNF-a) signal transduction through ceramide. J Biol Chem 268: 17762–17766
Dérijard B, Hibi M, Wu l-H, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025–1037
Deutscher SL, Bhat BM, Pursley MH, Cladaras C, Wold WSM (1985) Novel deletion mutants that enhance a distant upstream 5’ splice in the E3 transcription unit of adenovirus 2. Nucleic Acids Res 13: 5771–5788
Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA (1993) Ceramide activates heterotrimeric protein phosphatase2A. J Biol Chem 268: 15523–15530
Duerksen-Hughes P, Wold WSM, Gooding LR (1989) Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol 143: 4193–4200
Duerksen-Hughes PJ, Hermiston TW, Wold WSM, Gooding LR (1991) The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J Virol 65: 1236–1244
Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM (1994) Molecular cloning and functional analysis of the adenovirus E1 A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869–884
Flomenberg PR, Chen M, Horwitz MS (1987) Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J Virol 61: 3665–3671
Flomenberg PR, Chen M, Horwitz MS (1988) Sequence and genetic organization of adenovirus type 35 early region 3. J Virol 62: 4431–4437
Flomenberg P, Szmulewicz J, Gutierrez E, Lupatkin H (1992) Role of the adenovirus E3–19K conserved region in binding major histocompatibility complex class I molecules. J Virol 66: 4778–4783
Fox JP, Hall CE, Cooney MK (1977) The Seattle virus watch: observations of adenovirus infections. Am J Epidemiol 105: 362–386
Friedman DJ, Ricciardi RP (1988) Adenovirus type 12 E1A gene represses accumulation of MHC class I mRNAs at the level of transcription. Virology 165: 303–305
Gabathuler R, Levy F, Kvist S (1990) Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens. J Virol 64: 3679–3685
Garcia J, Wu F, Gaynor R (1987) Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter. Nucleic Acids Res 15: 8367–8385
Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86: 3823–3827
Gooding LR (1992) Virus proteins that counteract hose immune defenses. Cell 71: 5–7
Gooding LR, Wold WSM (1990) Molecular mechanisms by which adenovirus counteract antiviral immune defenses. CRC Crit Rev Immunol 10: 53–71
Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WSM (1988) A14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53: 341–346
Gooding LR, Sofola IO, Tollefson AE, Duerksen-Hughes P, Wold WSM (1990) The adenovirus E3–14. 7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J Immunol 145: 3080–3086
Gooding LR, Aquino L, Duerksen-Hughes PJ, Day D, Horton TM, Yei S, Wold WSM (1991a) The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol 65: 3083–3094
Gooding LR, Ranheim TS, Tollefson AE, Aquino L, Duerksen-Hughes P, Horton TM, Wold WSM (1991 b) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J Virol 65: 4114–4123
Grunhaus A, Horwitz MS (1992) Adenoviruses as cloning vectors. Semin Virol 3: 237–252
Grunhaus A, Cho S, Horwitz MS (1994) Association of vaccinia virus-expressed adenovirus E3–19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 200: 535–546
Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125–3128
Hannun YA, Bell RM (1993) The sphingomyelin cycle: a prototypic sphingolipid signaling pathway. Adv Lipid Res 25: 27–41
Hashimoto S, Ishii A, Yonehara S (1991) The E1 b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int Immunol 3: 343–351
Hawkins LK, Wold WSM (1992) A12,500 MW protein is coded by region E3 of adenovirus. Virology 188: 486–494
Hawkins LK, Wold WSM (1995) A 20 500-dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses. Virology (in press)
Hawkins LK, Wilson-Rawls J, Wold WSM (1995) Region E3 of subgroup B human adenoviruses encodes a 16,000 MW membrane protein that may be a distant analog of the E3–6.7K protein of subgroup C adenoviruses. J Virol (in press)
Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori T, Oku N, Ito F, Tsujimoto M (1993) Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 268: 11290–11295
Hérissé J, Galibert F (1981) Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome. Nucleic Acids Res 9: 1229–1240
Hérissé J, Courtois G, Galibert F (1980) Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome. Nucleic Acids Res 8: 2173–2192
Hennet T, Ziltener HJ, Frei K, Peterhans E (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149: 932–939
Hermiston TW, Hellwig R, Hierholzer JC, Wold WSM (1993a) Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates. Virology 197: 593–600
Hermiston TW, Tripp RA, Sparer T, Gooding LR, Wold WSM (1993b) Deletion mutant analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J Virol 67: 5289–5298
Hermiston TW, Tollefson AE, Bhat BM, Skdheer S, Davis A, Hung P, Wold WSM. DNA sequence of the E3 transcription unit of human adenovirus type 4 (manuscript in preparation)
Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA (1993) Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 90: 4475–4479
Hoffman P, Yaffe MB, Hoffman BL, Yei SP, Wold WSM, Carlin C (1992) Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. J Biol Chem 267: 13480–13487
Hong JS, Mullis KG, Engler JA (1988) Characterization of the early region 3 and fiber genes of Ad7. Virology 167: 545–553
Horton TM, Tollefson AE, Wold WSM, Gooding LR (1990) A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. J Virol 64: 1250–1255
Horton TM, Ranheim TS, Aquino L, Kusher Dl, Saha SK, Ware CF, Wold WSM, Gooding LR (1991) Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J Virol 65: 2629–2639
Horwitz MS (1990) Adenovirus. In: Fields BN, Knipe DM (eds) Virology, 2nd edn. Raven, New York, pp 1679–1721
Hurst HC, Jones NC (1987) Identification of factors that interact with the E1A-inducible adenovirus E3 promoter. Genes Dev 1: 1132–1146
Jackson MR, Nilsson T, Peterson PA (1990) Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9: 3153–3162
Jackson MR, Nifsson T, Peterson PA (1993) Retrieval of transmembrane proteins to the endoplasmic reticulum. J Cell Biol 121: 317–333
Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91: 73–77
Jefferies WA, Burgert H-G (1990) E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J Exp Med 172: 1653–1664
Johnson DG, Schwarz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352
Jones N, Shenk T (1979) Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683–689
Joseph CK, Byun H-S, Bittman R, Kolesnick RN (1993) Substrate recognition by ceramide-activated protein kinase. J Biol Chem 268: 20002–20006
Kämpe O, Beilgrau D, Hammerling U, Lind P, Pääbo S, Severinsson L, Peterson PA (1983) Complex formation of class I transplantation antigens and a viral glycoprotein. J Biol Chem 258:10594–10598
Kapoor QS, Wold WSM, Chinnadurai G (1981) A non-essential glycoprotein is coded by early region E3 of adenovirus type 7. Virology 112: 780–784
Kelly Jr TJ, Lewis Jr AM (1973) Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome. J Virol 12: 643–652
Kitchingman GR, Westphal H (1980) The structure of adenovirus 2 early nuclear and cytoplasmic RNAs. J Mol Biol 137: 23–48
Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325–328
Körner H, Burgert H-G (1994) Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J Virol 68: 1442–1448
Körner H, Fritzsche U, Burgert H-G (1992) Tumor necrosis factor a stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc Natl Acad Sci USA 89: 11857–11861
Kornfeld R, Wold WSM (1981) Structures of the oligosaccharides of the glycoprotein coded by early region E3 of adenovirus 2. J Virol 40: 440–449
Kornuc M, Kliewer S, Garcia J, Harrich D, Li C, Gaynor R (1990) Adenovirus early region 3 promoter regulation by E1 A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1. J Virol 64: 2004–2013
Kozak M (1987) An analysis of 5’-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125–8132
Krajcsi P, Wold WSM (1992) The adenovirus E3–14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187: 492–498
Krajcsi P, Tollefson AE, Anderson CW, Stewart AR, Carlin CR, Wold WSM (1992a) The E3–10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. Virology 187: 131–144
Krajcsi P, Tollefson AE, Anderson CW, Wold WSM (1992b) The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J Virol 66: 1665–1673
Krajcsi P, Tollefson AE, Wold WSM (1992c) The E3–14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosy- lated but not N-glycosylated. Virology 188: 570–579
Krönke M, Schütze S, Scheurich P, Pfizenmaier K (1992) TNF signal transduction and TNF-responsive genes. Immunol Ser 56: 189–216
Kuivinen E, Hoffman BL, Hoffman PA, Carlin CR (1993) Structurally related class I and Class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses. J Cell Biol 120: 1271–1279
Kvist S, Ostberg L, Persson H, Philipson L, Peterson PA (1978) Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci USA 75: 5674–5678
Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156–160
Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR (1992) Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 175: 1123–1129
Laster SM, Wood JG, Gooding LR (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141: 2629–2634
Lavery DJ, Fu SM, Lufkin T, Chen-Kiang S (1987) Productive infection of cultured human lymphoid cells by adenovirus. J Virol 61: 1466–1472
Lin L-L, Lin AY, Knopf JL (1992) Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89: 6147–6151
Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278
Lippé R, Luke E, Kuah YT, Lomas C, Jefferies WA (1991) Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins. J Exp Med 174: 1159–1166
Liu J, Mathias S, Yang Z, Kolesnick RN (1994) Renaturation and tumor necrosis factor-a stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 269: 3047–3052
Machleidt T, Wiegmann K, Henkel T, Schütze S, Baeuerle P, Krönke M (1994) Sphingomyelinase activates proteolytic Iκβ-α degradation in a cell-free system. J Biol Chem 269: 13760–13765
Mathias S, Kolesnick R (1993) Ceramide: a novel second messenger. Adv Lipid Res 25: 65–90
Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC (1992) Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 146: 177–184
Mayer A, Gelderblom H, Kümel G, Jungwirth C (1992) Interferon-γ-induced assembly block in the replication cycle of adenovirus 2: augmentation by tumor necrosis factor-a. Virology 187: 372–376
Mei Y-F, Wadell G (1992) The nucleotide sequence of adenovirus type 11 early 3 region: comparison of genome type Ad11 p and Ad11 a. Virology 191: 125–133
Mei Y-F, Wadell G (1993) Hemagglutination properties and nucleotide sequence analysis of the fiber gene of adenovirus genome types 11 p and 11a. Virology 194: 453–462
Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Möller A, Jacobsen H, Kirchner H (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323: 816–819
Moran E (1993) Interaction of adenoviral proteins with pRB and p53. FASEB J 7: 880–885
Morin JE, Lubeck MD, Barton JE, Conley AJ, Davis AR, Hung PP (1987) Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 84: 4626–4630
Nevins JR (1992) E2F: a link between the Rb tumor supressor protein and viral oncoproteins. Science 258: 424–429
Nevins JR, Ginsberg HS, Blanchard J-M, Wilson MC, Darnell Jr JE (1979) Regulation of the primary expression of the early adenovirus transcription units. J Virol 32: 727–733
Nilsson T, Jackson M, Peterson PA (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707–718
Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259: 1769–1771
Ozawa K, Hagiwara H, Tang X, Saka F, Kitabayashi I, Shiroki K, Fujinaga K, Israël A, Gachelin G, Yokoyama K (1993) Negative regulation of the gene for H-2Kb class I antigen by adenovirus 12-E1A is mediated by a CAA repeated element. J Biol Chem 268: 27258–27268
Pääbo S, Weber F, Kämpe O, Schaffner W, Peterson PA (1983) Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell 35: 445–453
Pääbo S, Nilsson T, Peterson PA (1986a) Adenoviruses of subgenera B, C, D, and E modulate cell- surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 83: 9665–9669
Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA (1986b) Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J 5:1921–1927
Pääbo S, Bhat BM, Wold WSM, Peterson PA (1987) A short sequence in the COOH terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50: 311–317
Pääbo S, Severinsson L, Andersson M, Martens I, Nilsson T, Peterson PA (1989) Adenovirus proteins and MHC expression. Adv Cancer Res 52: 151–163
Paya CV, Kenmotsu N, Schoon RA, Leibson PJ (1988) Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol 141: 1989–1995
Persson H, Öberg B, Philipson L (1978) Purification and characterization of an early protein (E14K) from adenovirus type 2-infected cells. J Virol 28: 119–139
Persson H, Signäs C, Philipson L (1979) Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells. J Virol 29: 938–948
Persson H, Jansson M, Philipson L (1980a) Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol 136: 375–394
Persson H, Jornväll H, Zabielski J (1980b) Multiple mRNA species for the precursor to an adenovirus- encoded glycoprotein: identification and structure of the signal sequence. Proc Natl Acad Sci USA 77: 6349–6353
Raines MA, Kolesnick RN, Golde DW (1993) Sphingomyelinase and ceramide activate mitogen- activated protein kinase in myeloid HL-60 cells. J Biol Chem 268: 14572–14575
Rammensee H-G, Falk K, Rötzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244
Ranheim TS, Shisler J, Horton TM, Wold LJ, Gooding LR, Wold WSM (1993) Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J Virol 67: 2159–2167
Rawle FC, Tollefson AE, Wold WSM, Gooding LR (1989) Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol 143: 2031–2037
Rawle FC, Knowles BB, Ricciardi RP, Brahmacheri V, Duerksen-Hughes P, Wold WSM (1991) Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1 A is immunodominant in H-2b, but not in H-2d or H-2k mice. J Immunol 146: 3977–3984
Roberts RJ, Akusjärvi G, Aleström P, Gelinas RE, Gingeras TR, Sciaky D, Pettersson U (1986) A consensus sequence for the adenovirus-2 genome. In: Doerfler WE (ed) Adenovirus DNA, the viral genome and its expression. Nijhoff, Boston, pp 1–51
Ross S, Levine AJ (1979) The genomic map position of the adenovirus type 2 glycoprotein. Virology 99: 427–430
Routes JM, Metz BA, Cook JL (1993) Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression. J Virol 67: 3176–3181
Scaria A, Wold WSM (1994) Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus. Virology 205: 406–416
Scaria A, Tollefson AE, Saha SK, Wold WSM (1992) The E3–11.6K protein of adenovirus is an Asn-glyco- sylated integral membrane protein that localizes to the nuclear membrane. Virology 191: 743–753
Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M (1992) TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 71: 765–776
Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, van der Eb AJ (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305: 771–775
Severinsson L, Martens I, Peterson PA (1986) Differential association between two human MHC class I antigens and an adenoviral glycoprotein. J Immunol 137: 1003–1009
Shaw AR, Ziff EB (1980) Transcripts from the adenovirus-2 major late promoter yield a single early family of 3’ coterminal mRNAs and five late families. Cell 22: 905–916
Shemesh J, Rotem-Yehudar R, Ehrlich R (1991) Transcriptional and postranscriptional regulation of class I major histocompatibility complex genes following transformation with human adenoviruses. J Virol 65: 5544–5548
Signäs C, Katze MG, Persson H, Philipson L (1982) An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature 299: 175–178
Signäs C, Akusjärvi G, Pettersson U (1986) Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene 50: 173–184
Silver J, Anderson CW (1988) Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology 165: 377–387
Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959–962
Smith GL (1994) Virus strategies for evasion of the host response to infection. Trends Microbiol 2: 81–88
Sprengel J, Schmitz B, Heuss-Neitzel D, Zock C, Doerfler W (1994) Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis. J Virol 68: 379–389
Stålhandske P, Persson H, Perrieaudet M, Philipson L, Pettersson U (1983) Structure of three spliced mRNAs from region E3 of adenovirus type 2. Gene 22: 157–165
Stein R, Ziff EB (1984) HeLa cell beta-tubulin gene transcription is stimulated by adenovirus 5 in parallel with viral early genes by an E1a-dependent mechanism. Mol Cell Biol 4: 2792–2801
Stewart AR, Tollefson AE, Krajcsi P, Yei S-P, Wold WSM (1995) The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to downregulate the epidermal growth factor receptor, are localized in the plasma membrane. J Virol 69: 172–181
Suffys P, Beyaert R, DeValck D, Vanhaesebroeck B, Van Roy F, Fiers W (1991) Tumour-necrosis-factor- mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem 195: 465–475
Tanaka Y, Tevethia SS (1988) Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb-and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology 165: 357–366
Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853
Tollefson AE, Wold WSM (1988) Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses. J Virol 62: 33–39
Tollefson AE, Krajcsi P, Pursley MH, Gooding LR, Wold WSM (1990a) A 14,500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175: 19–29
Tollefson AE, Krajcsi P, Yei S, Carlin CR, Wold WSM (1990b) A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus. J Virol 64: 794–801
Tollefson AE, Stewart AR, Yei S, Saha SK, Wold WSM (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J Virol 65: 3095–3105
Tollefson AE, Scaria A, Saha SK, Wold WSM (1992) The 11,600-Mw protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J Virol 66: 3633–3642
Tufariello J, Cho S, Horwitz MS (1994) The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J Virol 68: 453–462
Uhlen M, Svensson C, Josephson S, Aleström P, Chattapadhyaya JB, Pettersson U, Philipson L (1982) Leader arrangement in the adenovirus fiber mRNA. EMBO J 1: 249–254
Van Lint J, Agostinis P, Vandevoorde V, Haegeman G, Fiers W, Merlevede W, Vandenheede JR (1992) Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. J Biol Chem 267: 25916–25921
Vasavada R, Eager KB, Barbanti-Brodano G, Caputo A, Ricciardi RP (1986) Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. Proc Natl Acad Sci USA 83: 5257–5261
Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411–452
Vietor I, Schwenger P, Li W, Schlessinger J, Vilcek J (1993) Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J Biol Chem 268: 18994–18999
Vilcek J, Lee TH (1991) Tumor necrosis factor. J Biol Chem 266: 7313–7316
Wang EW, Scott MO, Ricciardi RP (1988) An adenovirus mRNA which encodes a 14,700-Mr protein that maps to the last open reading frame in region E3 is expressed during infection. J Virol 62:1456–1459
White E, Cipriani R (1989) Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1 B oncogene. Proc Natl Acad Sci USA 86: 9886–9890
White E, Cipriani R (1990) Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol Cell Biol 10: 120–130
White E, Sabbatini P, Debbas M, Wold WSM, Kusher Dl, Gooding LR (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol Cell Biol 12: 2570–2580
Wiegmann K, Schütze S, Kampen E, Himmler A, Machleidt T, Kränke M (1992) Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 267: 17997–18001
Williams JL, Garcia J, Harrich D, Pearson L, Wu F, Gaynor R (1990) Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-k binding motifs. EMBO J 9: 4435–4442
Wilson-Rawls J, Wold WSM (1993) The E3–6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum. Virology 195: 6–15
Wilson-Rawls J, Saha SK, Krajcsi P, Tollefson AE, Gooding LR, Wold WSM (1990) A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. Virology 178: 204–212
Wilson-Rawls J, Deutscher SL, Wold WSM (1994) The signal-anchor domain of adenovirus E3–6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum. Virology 201: 66–76
Wold WSM (1993) Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J Cell Biochem 53: 329–335
Wold WSM, Gooding LR (1989) Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol Biol Med 6: 433–452
Wold WSM, Gooding LR (1991) Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1–8
Wold WSM, Cladaras C, Magie SC, Yacoub N (1984) Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2. J Virol 52: 307–313
Wold WSM, Cladaras C, Deutscher SL, Kapoor QS (1985) The 19-kDa glycoprotein coded by region E3 of adenovirus: Purification, characterization, and structural analysis. J Biol Chem 260: 2424–2431
Wold WSM, Deutscher SL, Takemori N, Bhat BM, Magie SC (1986) Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA in region E3 of adenovirus. Virology 148: 168–180
Wong GHW, Goeddel DV (1986) Tumour necrosis factors a and ß inhibit virus replication and synergize with interferons. Nature 323: 819–822
Yewdell JW, Bennink JR, Eager KB, Ricciardi RP (1988) CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Virology 162: 236–238
Zilli D, Voelkel-Johnson C, Skinner T, Laster SM (1992) The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem Biophys Res Commun 188: 177–183
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wold, W.S.M., Tollefson, A.E., Hermiston, T.W. (1995). E3 Transcription Unit of Adenovirus. In: Doerfler, W., Böhm, P. (eds) The Molecular Repertoire of Adenoviruses I. Current Topics in 199/I Microbiology and Immunology, vol 199/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79496-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-79496-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79498-8
Online ISBN: 978-3-642-79496-4
eBook Packages: Springer Book Archive